ERTEK, SIBEL
 Distribuzione geografica
Continente #
NA - Nord America 170
EU - Europa 68
AS - Asia 43
AF - Africa 6
Totale 287
Nazione #
US - Stati Uniti d'America 170
GB - Regno Unito 28
CN - Cina 25
DE - Germania 12
IN - India 7
SG - Singapore 6
IT - Italia 5
RU - Federazione Russa 4
SE - Svezia 4
UA - Ucraina 4
CI - Costa d'Avorio 3
EE - Estonia 3
FR - Francia 3
ID - Indonesia 3
IE - Irlanda 3
ZA - Sudafrica 3
JO - Giordania 2
CH - Svizzera 1
FI - Finlandia 1
Totale 287
Città #
Southend 27
Wilmington 22
Fairfield 19
Seattle 14
Houston 13
Santa Clara 13
Ashburn 11
Woodbridge 9
Chandler 8
Ann Arbor 7
Princeton 6
Singapore 5
Jinan 4
Abidjan 3
Boardman 3
Bremen 3
Dublin 3
Nanjing 3
Padova 3
Semarang 3
Westminster 3
Amman 2
Cambridge 2
Dearborn 2
Falls Church 2
Hebei 2
Jiaxing 2
Nanchang 2
San Diego 2
Shanghai 2
Zhengzhou 2
Frankfurt Am Main 1
Fuzhou 1
Hangzhou 1
Helsinki 1
Norwalk 1
Olalla 1
Pune 1
Saint Petersburg 1
Shenyang 1
Suzhou 1
Taizhou 1
Wenzhou 1
Totale 214
Nome #
Efficacy and safety profile of evolocumab (AMG145), an injectable inhibitor of the proprotein convertase subtilisin/kexin type 9: the available clinical evidence. 107
Safety and tolerability of injectable lipid-lowering drugs: a review of available clinical data 98
Nutraceuticals for metabolic syndrome management: from laboratory to benchside. 85
Totale 290
Categoria #
all - tutte 762
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 762


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202064 0 0 0 0 0 0 13 18 23 5 2 3
2020/202123 8 4 0 2 0 0 0 0 6 0 0 3
2021/202247 3 0 3 3 4 2 0 6 0 0 13 13
2022/202347 3 3 1 5 3 3 4 3 14 2 3 3
2023/202415 4 3 0 0 1 0 0 0 1 2 4 0
2024/202533 0 7 4 6 15 1 0 0 0 0 0 0
Totale 290